期刊文献+

头孢地尼的药理及临床应用 被引量:5

下载PDF
导出
摘要 头孢地尼是第三代口服广谱头孢菌素 ,对很多革兰阳性和革兰阴性需氧菌有良好的抗菌活性。临床上对上下呼吸道感染及皮肤软组织感染等效果良好。本文对其抗菌活性、药动学性质及临床应用等作一介绍。
作者 傅得兴
机构地区 卫生部北京医院
出处 《中国全科医学》 CAS CSCD 2004年第17期1252-1254,共3页 Chinese General Practice
  • 相关文献

参考文献10

  • 1张慧琳,侯杰,陈旭岩,朱学俊,李晓晶,谭伟,王爱平,肖永红,曹爱中,辛小娟,陈海,李德天,马成林,刘勇,何礼贤,王葆青.头孢地尼与头孢特伦多中心随机对照临床研究[J].中国抗生素杂志,2003,28(9):555-561. 被引量:13
  • 2Fogarty CM,Bettis RB,Griffin TJ,et al.Comprison of a day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acut exacerbation of chronic bronchitis[J].J Antimicrob agent chemother,2000,45:851-858.
  • 3Paster RZ,McAdoo MA,Keserling CH,et al.A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acut exacerbations of chronic bronchitis[J].Int j clin pract,2000,293-299.
  • 4David RP.Guay.Cefdinir:An advanced-generation,broad-spectrum oral cephalosporin[J].Clinical therapeutics,2002,24(4):473-489.
  • 5Walsh PM.Physician desk reference[M].57ed.Montvale NJ:Thomson PDR,2003.489-493.
  • 6Drehobl M,Bianchi P,Keyserling CH,et al.Comparison of cefdinir and cefaclor in treament of community-acquired pneumonira[J].J Antimicrob agent chemother,1997,41:1579-1583.
  • 7Block SL,Hedrick JA,Kratzer J,et al.Five-day twice daily cefdinir therapy for acut otitis media:Microbiologic and clinicl efficacy[J].Pediat infect dis j,2000,19(suppl 12):153-158.
  • 8Block SL,McCarty JM,Hedrick JA,et al.amoxicillin/clavulanate for treatment of suppurative acut otitis media in children[J].Pediat infect dis j,2000,19(12):159-165.
  • 9Pchichero ME,Manford gooh Ⅲ.W.Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis[J].Pediat infect dis j,2000,19:171-173.
  • 10肖永红,白群华,姚 成,余泽波,陈 海.头孢地尼对临床分离菌的体外抗菌活性[J].中国抗感染化疗杂志,2001,1(4):203-206. 被引量:6

二级参考文献14

  • 1Fung-Tomc J C, Huczko E, Sticule T, et al. Antimicrobial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides[J]. Antimicrob Agents Chemother,1995,39(2) :533.
  • 2Tamura S, Miyazaki S, Tateda K, et al. In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricycic antibiotic [J]. Antimicrob Agents Chemother,1998,42(7):1858.
  • 3Fukuoka T, Ohya S, Utsui Y, et al. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem[J]. Antimicrob Agents Chemother , 1997,41 (12) : 2652.
  • 4Hikida M, Itahashi K, Igarashi A, et al. In vivo antibacterial activitiy of LJC 11,036, an active metabolite of L-084, a new oral carbapem antibiotic with potent antipneumococcal activity[J]. Antimicrob Agents Ckemotker,1999,43(8) :2010.
  • 5Richer M, Allard S, Manseau L, et al. Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses [J]. Antimlcrob Agents Chemother,1995,39(5):1082.
  • 6Guay O R P. Cefdinir: an advanced-generation, broadspectrum oral cephalosporin [J]. Clin Ther,2002,24(4):473.
  • 7Sperling M J, Puopolo A, Griffin T J, et al. Efficacy and safety cefdinir in the treatment of patients with acute bronchitis[J]. Clin Ther,1996,18(4) :626.
  • 8Fogart C M, Bianehi P, Eyserling C H, et al. Comparison of a 5 day regimen of eefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis[J]. J Antimicrob Chemothe, 2000,45() : 851.
  • 9Orchobl M, Bianchi P, Eyserling C H, et al. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia[J]. Antimicrob Agents Chemother,1997,41(7):1579.
  • 10Wise R, Andrews JM, Thornber D. Thein vitro activity of cefdinir , a new oral cephalosporin [J]. J Antimicrob Chemother,1991,28(2):239-248

共引文献16

同被引文献51

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部